Administering low-dose prednisolone to patients with inflammatory rheumatologic disease without diabetes mellitus can interrupt carbohydrate metabolism, according to a small study in Diabetes Care. "Our findings demonstrate that low-dose prednisolone exerts a major deleterious effect on carbohydrate metabolism. When prescribing glucocorticoids, careful consideration should be given to these potential adverse metabolic effects, and alternative anti-inflammatory agents should be considered," researchers said.

Related Summaries